What is MEDDIC sales methodology
MEDDIC is a B2B sales qualification framework used to predict and close complex deals. Learn the six components and how teams train reps on it in 2026.
Summary
MEDDIC is a qualification framework for complex B2B deals, not a pitch script.
It stands for Metrics, Economic buyer, Decision criteria, Decision process, Identify pain, and Champion.
The point is forecast accuracy: knowing which deals are real and which are stories reps tell themselves.
Most teams fail at MEDDIC not because they do not understand it, but because they cannot execute it under pressure.
MEDDIC turns into muscle memory through practice, not through reading about it.
The forecast meeting nobody wants to have
Every sales leader has sat in the same forecast meeting. A rep walks through a deal with confidence. The buyer is excited. The demo went well. Procurement has been looped in. The close date is this quarter.
Two weeks later, the deal slips. Then it slips again. Then it disappears.
Sales Leader: "What happened?"
Rep: "They went with the incumbent. Budget got reallocated."
Sales Leader: "Did you know the economic buyer?"
Rep: "I was mostly talking to the director of ops."
This scene has played out in every enterprise sales org since the 1990s. It is the reason MEDDIC exists. Not as a methodology to make reps sound smarter, but as a filter that forces the question: do we actually know what we need to know to win this deal?
MEDDIC was developed at PTC in the early 1990s by Dick Dunkel and Jack Napoli, two sales leaders who were tired of forecasts that looked strong on paper and collapsed in practice. The framework is deceptively simple. Six letters, each representing one piece of information a rep needs to confirm before calling a deal real. Behind that simplicity is a discipline that takes most reps years to build.
What people think MEDDIC is, and what it actually is
The cartoon version
Most reps first encounter MEDDIC as a form. The CRM has fields for each letter. The rep fills them in before a deal review. The manager skims the fields, asks a few questions, and moves on. MEDDIC becomes paperwork.
Manager: "Did you fill out the MEDDIC fields?"
Rep: "Yes."
Manager: "Great, moving on."
This version of MEDDIC is harmless and useless. The fields get filled with generic answers that would apply to any deal. The economic buyer is "the CFO probably." The metrics are "save time and money." The champion is "the VP who took the demo." None of this is qualification. It is hygiene theater.
What MEDDIC actually is
Real MEDDIC is a conversation the rep has with themselves and the buyer, repeated throughout the deal, about what is actually true. Each letter is a test: can I name it specifically, or am I guessing?
A rep who has done real MEDDIC can tell you the economic buyer's name, their role, what they care about this quarter, and how they make decisions. They can tell you the specific metric the buyer is being measured on and how your product moves it. They can describe the decision process stage by stage, including procurement, legal, and security. They have a named champion who has sold on their behalf in a meeting they were not in.
A rep who has not done real MEDDIC describes the same deal in vibes. The buyer is interested. The demo went well. They are evaluating options. Pricing will probably work out. This is where forecasts go to die.
Breaking down the six letters
Metrics
Metrics are the quantifiable business outcomes the buyer cares about. Not product outcomes. Business outcomes. A vendor might save the buyer's team 200 hours a month, but the metric that matters is what those 200 hours translate into: three more product launches a year, two fewer missed deadlines, a 5% reduction in cycle time.
Reps get metrics wrong in two predictable ways. Either they list features instead of outcomes (our platform has advanced analytics) or they list generic benefits instead of buyer-specific ones (we save customers time and money). Real metrics come from the buyer, not the rep. The question is: what are you being measured on, and how would a solution like ours move that number?
Economic buyer
The economic buyer is the person who can unilaterally approve the spend. Not the person who introduced you to the company. Not the VP who attended the demo. The person who, when it comes down to it, says yes or no and has no one to check with.
This is the letter reps mess up most often. They confuse the champion with the economic buyer. They assume the person they have the best relationship with is the one making the decision. In complex deals, the economic buyer is usually someone the rep has met once, if at all. A disciplined MEDDIC practitioner asks early: who else needs to sign off on this? And who signs off on that person?
Decision criteria
Decision criteria are the specific, often written requirements a solution has to meet to be considered. Must integrate with Salesforce. Must support SSO. Must have a certified integration with our data warehouse. Must be SOC 2 Type II compliant.
The rep's job is to know these criteria and make sure they are not accidentally disqualifying themselves on a box they could actually check. A surprising number of deals die because a rep did not realize the buyer had added a requirement mid-process.
Decision process
The decision process is how the buyer actually buys. Who is involved at which stage. What happens after the rep wins the commercial conversation (procurement? security review? legal?). How long each stage typically takes. What signatures are needed.
This letter is where deals slip. A rep who has identified metrics, economic buyer, decision criteria, and pain but has not mapped the decision process will watch the deal push out by a quarter because they discovered security review existed three weeks before quarter-end. A rep who mapped the process on the first discovery call already had security involved when it mattered.
Identify pain
Identify pain is about naming the specific problem your product solves for this buyer and what happens if they do not solve it. Pain in MEDDIC is not "things could be better." Pain is "we are losing 20 deals a quarter because our reps cannot ramp fast enough, and our CRO is under pressure from the board to fix it."
The test is: if you asked the buyer to describe why this project exists in their own words, would the description sound urgent, specific, and expensive? If not, the pain is not really identified, it is just sketched.
Champion
A champion is someone inside the account who wants you to win and will sell on your behalf when you are not in the room. Not a coach, who is happy to share information but has no political capital. Not a fan, who says nice things but would not go to the mat. A real champion pushes back on internal objections, defends the project when priorities shift, and introduces the rep to people they need to meet.
The test of a champion is simple. Can they answer these three questions: what does our product do, why does your company need it, and who inside your company is blocking it? If they can, they are a champion. If they hedge on any of the three, they are not.
MEDDPICC and the extended version
Some teams use MEDDPICC, which adds two letters: Paper process (legal, procurement, security review, anything that adds time between commercial close and signature) and Competition (who else the buyer is considering and what edge they have).
Both additions reflect how B2B buying has actually evolved. Paper process acknowledges that signing an enterprise deal in 2026 involves more stakeholders than it did in 2000. Competition acknowledges that almost no category is un-contested anymore, and pretending the buyer is only looking at you is a fast way to lose deals to vendors you did not know were in the room.
Both versions serve the same purpose: a forecast that reflects reality instead of hope. Which variant a team uses matters less than whether they actually execute it.
Where MEDDIC breaks down in real life
When it becomes a form, not a conversation
The most common failure is filling in MEDDIC fields without actually doing the work. A rep writes "CFO" under economic buyer without having talked to the CFO. The manager sees a filled-in field and assumes the work happened. The deal carries through forecast until the CFO says no and nobody saw it coming.
Good managers check by asking reps to describe each letter in their own words, live, without looking at the CRM. A rep who can describe the economic buyer's priorities and the pain specifically has done the work. A rep who reaches for the CRM tab has not.
When reps confuse titles with roles
MEDDIC is hard because the real economic buyer, champion, and influencer roles do not map cleanly to org charts. A VP can be a champion or an obstacle. A director can be the economic buyer if they have the budget. A senior individual contributor can be the most influential person in the deal. Reps who assume title equals role get surprised.
When the conversation skill lags the framework knowledge
This is the quiet failure mode. A rep reads about MEDDIC, understands every letter, and still cannot run a discovery call that uncovers the information. The framework is knowledge. Uncovering metrics from a defensive CFO, identifying a champion through a series of conversations, or mapping a complex decision process while keeping the buyer engaged requires skill. Skill only comes from practice.
This is the gap most teams underinvest in. Reps read about MEDDIC in onboarding, fill out the fields in the CRM for the rest of their career, and never actually build the conversational muscle to do it well. That is the problem SecondBody was built to solve, letting reps practice MEDDIC-driven discovery calls against an AI buyer tuned to their ICP, with specific feedback on which letters they uncovered and which they skipped, until the framework becomes how they actually sell rather than a checklist they fill in after the call.
Why MEDDIC still matters in 2026
Some critics argue MEDDIC is dated, that modern buyers are more self-serve, that product-led growth has changed the math. There is truth in the critique for some segments. In high-velocity SMB sales, MEDDIC is heavy for the deal size. In true product-led motions, the framework is mostly irrelevant because the buyer qualifies themselves.
In enterprise and mid-market B2B, though, MEDDIC has aged well. The reasons are simple. Buying committees have grown, not shrunk. The average enterprise deal now involves six to ten stakeholders. Procurement, security, and legal reviews have gotten more rigorous, not less. Pressure on forecast accuracy has increased as boards and public markets punish revenue misses. The core job MEDDIC was built to do, helping reps tell real deals from stories, is more relevant than ever.
What has changed is how teams train on it. In the 1990s, training on MEDDIC meant a week-long workshop and a laminated card. In 2026, it means live practice scenarios, AI-graded discovery calls, and dashboards that show managers exactly which letters each rep is weakest on. The framework is the same. The reps are finally available.
A last thought
The thing most people miss about MEDDIC is that it is less a sales methodology and more a way of paying attention. The discipline is not memorizing six letters. The discipline is refusing to believe your own story about a deal until you have evidence.
Reps who internalize that discipline tend to become the ones other reps learn from. They forecast accurately because they walk away from deals that are not real. They close bigger deals because the ones they commit to are the ones where they have done the work. They coach peers because their discipline is contagious.
MEDDIC is not magic. It is a commitment to know what you do not know, and to keep asking until you do. Teams that take that seriously sell better. Teams that fill in the fields and move on sell about the same as they always have.
FAQ
What does MEDDIC stand for?
MEDDIC stands for Metrics, Economic buyer, Decision criteria, Decision process, Identify pain, and Champion. Each letter represents a piece of information a rep needs to confirm in order to accurately qualify a complex B2B deal. The extended version, MEDDPICC, adds Paper process and Competition.
Is MEDDIC a sales methodology or a qualification framework?
MEDDIC is a qualification framework, not a full sales methodology. It tells a rep what information they need to know about a deal but not how to run a discovery call, handle objections, or structure a demo. Most teams pair MEDDIC with a conversational methodology like SPIN Selling or Challenger, which covers the how. Together they form a more complete system.
When should a team use MEDDIC versus BANT?
BANT is lightweight and works well for high-velocity, transactional B2B sales where deals close in days or weeks and one or two stakeholders are involved. MEDDIC is designed for complex enterprise sales where deals involve six or more stakeholders, sales cycles run multiple quarters, and forecast accuracy matters. Using MEDDIC on a $2,000 deal is overkill. Using BANT on a $500,000 deal is malpractice.
How do you train reps on MEDDIC effectively?
Reading about MEDDIC takes an hour. Running it consistently on live deals takes months of practice. The most effective training combines three things: a clear written playbook showing how each letter applies to your specific ICP, role-play or AI-powered practice where reps rehearse uncovering each letter in realistic conversations, and ongoing deal reviews where managers stress-test each letter by asking the rep to describe it in their own words. Skipping any of the three leaves gaps.
What is the difference between a champion and an economic buyer?
A champion is someone inside the buyer's organization who wants you to win and sells on your behalf internally. An economic buyer is the person who can unilaterally approve the purchase. They can be the same person, but usually are not. The champion is often a director or manager who has the pain and will fight for the project. The economic buyer is often a VP or C-level executive who controls the budget and sees the project through the champion's advocacy.